NCT06994208
- Conditions
- Melanoma, Melanoma of Skin, Neoplasms, +10 more
- Locations
-
- E.O. Ospedali Galliera Genoa, Liguria, Italy
Clinical trial condition
Melanoma of Skin
Explore clinical trials studying Melanoma of Skin. Study availability and eligibility vary by location and protocol.
9 public trials
5 recruiting studies
Melanoma of Skin trial results
NCT07031830
- Conditions
- Melanoma, Melanoma of Skin, Neoplasms, +10 more
- Locations
-
- University Rouen Hospital Rouen, France
NCT06965231
- Conditions
- Acral Melanoma, Melanoma, Melanoma of Skin, +12 more
- Locations
-
- Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Cancer center, Shanghai 411 hospital, China RongTong Medical Healthcare Group Co.Ltd./411 Hospital, Shanghai University Shanghai, Shanghai Municipality, China
- Department of Surgical Oncology, Fudan University Shanghai Cancer Center Minhang Branch Hospital Shanghai, Shanghai Municipality, China
- Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT06765850
- Conditions
- Melanoma, Melanoma of Skin, Neoplasms, +10 more
- Locations
-
- University Hospital Carl Gustav Carus Dresden, Saxony, Germany
NCT06602648
- Conditions
- Melanoma, Melanoma of Skin, Neoplasms, +10 more
- Locations
-
- University of Florence Florence, Italy
Not Yet Recruiting
An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.
NCT06661577
- Conditions
- Acral Melanoma, Benign Skin Nevus, Benign Skin Tumor, +21 more
- Locations
-
- Manukau Super clinic Auckland, New Zealand
- Sir Willliam Manchester Plastic surgery suite, Middlemore Hosptial Auckland, New Zealand
NCT06654999
- Conditions
- Basal Cell Cancer, Melanoma, Melanoma of Skin, +16 more
- Locations
-
- Norwich and Norfolk Hospitals Trust Norwich, United Kingdom
- University Hospitals Dorset Poole, United Kingdom
- Surrey and Sussex Hospital Trust Redhill, United Kingdom
NCT02431676
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +63 more
- Locations
-
- Johns Hopkins ProHealth Baltimore, Maryland, United States
Active, Not Recruiting
Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma
NCT06784648
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +27 more
- Locations
-
- Charité - Universitatsmedizin Berlin Berlin, Germany
- University Hospital Essen Essen, Germany
- University Hospital Heidelberg Heidelberg, Germany
- University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg and Clinical Cooperation Unit Dermato-Oncology(G300) German Cancer Research Center(DKFZ) Mannheim, Germany